Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3048% below fair value
$139.98−5.36 (-3.69%)
Close on Nov 18, 2026Market cap $9.71BP/E 22.8Yield –
Insulet free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Insulet's free cash flow for the twelve months ending Sep 30, 2026 was $260.00M, down 38.6% year over year. For fiscal 2025 it was $377.70M, up 23.7% from the year before. The highest annual figure on record is $377.70M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $377.70M | +23.7% |
| FY2024 | Dec 31, 2024 | $305.30M | +335.5% |
| FY2023 | Dec 31, 2023 | $70.10M | – |
| FY2022 | Dec 31, 2022 | -$3.90M | – |
| FY2021 | Dec 31, 2021 | -$180.00M | – |
| FY2020 | Dec 31, 2020 | -$45.00M | – |
| FY2019 | Dec 31, 2019 | -$65.30M | – |
| FY2018 | Dec 31, 2018 | -$121.50M | – |
| FY2017 | Dec 31, 2017 | -$32.50M | – |
| FY2016 | Dec 31, 2016 | -$6.20M | – |
| FY2015 | Dec 31, 2015 | -$23.16M | – |
| FY2014 | Dec 31, 2014 | -$2.57M | – |
| FY2013 | Dec 31, 2013 | -$3.96M | – |
| FY2012 | Dec 31, 2012 | -$40.05M | – |
| FY2011 | Dec 31, 2011 | -$36.57M | – |
| FY2010 | Dec 31, 2010 | -$42.17M | – |
| FY2009 | Dec 31, 2009 | -$52.46M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $66.40M | -33.7% |
| Q2 FY2026 | Jun 30, 2026 | $55.90M | -68.6% |
| Q1 FY2026 | Mar 31, 2026 | $89.50M | +73.8% |
| Q4 FY2025 | Dec 31, 2025 | $48.20M | -48.7% |
| Q3 FY2025 | Sep 30, 2025 | $100.10M | +22.7% |
| Q2 FY2025 | Jun 30, 2025 | $177.90M | +176.7% |
| Q1 FY2025 | Mar 31, 2025 | $51.50M | -21.4% |
| Q4 FY2024 | Dec 31, 2024 | $93.90M | +490.6% |
| Q3 FY2024 | Sep 30, 2024 | $81.60M | +127.3% |
| Q2 FY2024 | Jun 30, 2024 | $64.30M | +127.2% |
| Q1 FY2024 | Mar 31, 2024 | $65.50M | – |
| Q4 FY2023 | Dec 31, 2023 | $15.90M | – |
| Q3 FY2023 | Sep 30, 2023 | $35.90M | +40.2% |
| Q2 FY2023 | Jun 30, 2023 | $28.30M | +164.5% |
| Q1 FY2023 | Mar 31, 2023 | -$10.00M | – |
| Q4 FY2022 | Dec 31, 2022 | -$13.70M | – |
| Q3 FY2022 | Sep 30, 2022 | $25.60M | – |
| Q2 FY2022 | Jun 30, 2022 | $10.70M | – |
| Q1 FY2022 | Mar 31, 2022 | -$26.50M | – |
| Q4 FY2021 | Dec 31, 2021 | -$57.30M | – |
| Q3 FY2021 | Sep 30, 2021 | -$53.10M | -400.0% |
| Q2 FY2021 | Jun 30, 2021 | -$1.60M | -200.0% |
| Q1 FY2021 | Mar 31, 2021 | -$68.00M | – |
| Q4 FY2020 | Dec 31, 2020 | -$33.80M | – |
| Q3 FY2020 | Sep 30, 2020 | $17.70M | +110.7% |
| Q2 FY2020 | Jun 30, 2020 | $1.60M | – |
| Q1 FY2020 | Mar 31, 2020 | -$30.50M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.20M | – |
| Q3 FY2019 | Sep 30, 2019 | $8.40M | – |
| Q2 FY2019 | Jun 30, 2019 | -$33.60M | – |
| Q1 FY2019 | Mar 31, 2019 | -$37.90M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.11M | – |
| Q3 FY2018 | Sep 30, 2018 | -$21.27M | -246.4% |
| Q2 FY2018 | Jun 30, 2018 | -$58.49M | -1378.4% |
| Q1 FY2018 | Mar 31, 2018 | -$39.64M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.09M | -123.9% |
| Q3 FY2017 | Sep 30, 2017 | $14.53M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.58M | – |
| Q1 FY2017 | Mar 31, 2017 | -$47.51M | – |
| Q4 FY2016 | Dec 31, 2016 | $17.16M | – |
See a number that looks wrong?